Structure-based Design of Compounds Inhibiting Grb2-SH2 Mediated Protein-protein Interactions in Signal Transduction Pathways

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|18|1777-1796

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.18, 2000-12, pp. : 1777-1796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Accommodating Protein Flexibility for Structure-Based Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-01 ,pp. : 171-178

Bentham Science Publishers

Access to resources Recommend Favorite

The Src Homology-2 Domains (SH2 Domains) of the Protein Tyrosine Kinase p56 lck Structure, Mechanism and Drug Design

By  

Current Drug Targets, Vol. 1, Iss. 4, 2000-01 ,pp. : 365-386

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 5, 2006-02 ,pp. : 529-548

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Drug Design Targeting Protein-Protein Interactions

By  

Current Drug Metabolism, Vol. 18, Iss. 9, 2012-03 ,pp. : 1240-1254

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Drug Design Targeting Protein-Protein Interactions

By  

Current Pharmaceutical Design, Vol. 18, Iss. 9, 2012-03 ,pp. : 1240-1254

Bentham Science Publishers

Access to resources Recommend Favorite